US20150284308A1 - Extraction and purification of urushiol from botanical sources - Google Patents
Extraction and purification of urushiol from botanical sources Download PDFInfo
- Publication number
- US20150284308A1 US20150284308A1 US14/646,198 US201314646198A US2015284308A1 US 20150284308 A1 US20150284308 A1 US 20150284308A1 US 201314646198 A US201314646198 A US 201314646198A US 2015284308 A1 US2015284308 A1 US 2015284308A1
- Authority
- US
- United States
- Prior art keywords
- solvent
- urushiol
- plant
- extract
- trees
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DQTMTQZSOJMZSF-UHFFFAOYSA-N urushiol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DQTMTQZSOJMZSF-UHFFFAOYSA-N 0.000 title claims abstract description 134
- RMTXUPIIESNLPW-UHFFFAOYSA-N 1,2-dihydroxy-3-(pentadeca-8,11-dienyl)benzene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1O RMTXUPIIESNLPW-UHFFFAOYSA-N 0.000 title claims abstract description 128
- QARRXYBJLBIVAK-UEMSJJPVSA-N 3-[(8e,11e)-pentadeca-8,11-dienyl]benzene-1,2-diol;3-[(8e,11e)-pentadeca-8,11,14-trienyl]benzene-1,2-diol;3-[(8e,11e,13e)-pentadeca-8,11,13-trienyl]benzene-1,2-diol;3-[(e)-pentadec-8-enyl]benzene-1,2-diol;3-pentadecylbenzene-1,2-diol Chemical compound CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O.CCCCCC\C=C\CCCCCCCC1=CC=CC(O)=C1O.CCC\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.C\C=C\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.OC1=CC=CC(CCCCCCC\C=C\C\C=C\CC=C)=C1O QARRXYBJLBIVAK-UEMSJJPVSA-N 0.000 title claims abstract description 128
- IYROWZYPEIMDDN-UHFFFAOYSA-N 3-n-pentadec-8,11,13-trienyl catechol Natural products CC=CC=CCC=CCCCCCCCC1=CC=CC(O)=C1O IYROWZYPEIMDDN-UHFFFAOYSA-N 0.000 title claims abstract description 128
- 238000000605 extraction Methods 0.000 title abstract description 39
- 238000000746 purification Methods 0.000 title abstract description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 141
- 239000002904 solvent Substances 0.000 claims abstract description 87
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 77
- 238000000034 method Methods 0.000 claims abstract description 61
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000000284 extract Substances 0.000 claims abstract description 48
- 241000196324 Embryophyta Species 0.000 claims abstract description 41
- 241000159243 Toxicodendron radicans Species 0.000 claims abstract description 39
- 241000159241 Toxicodendron Species 0.000 claims abstract description 14
- 239000003960 organic solvent Substances 0.000 claims abstract description 9
- 239000012501 chromatography medium Substances 0.000 claims abstract description 4
- 238000005194 fractionation Methods 0.000 claims abstract description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 80
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 78
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000000741 silica gel Substances 0.000 claims description 26
- 229910002027 silica gel Inorganic materials 0.000 claims description 26
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 19
- 239000002609 medium Substances 0.000 claims description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- 239000000287 crude extract Substances 0.000 claims description 10
- 240000006711 Pistacia vera Species 0.000 claims description 8
- 235000020226 cashew nut Nutrition 0.000 claims description 8
- 241000208223 Anacardiaceae Species 0.000 claims description 7
- 235000004936 Bromus mango Nutrition 0.000 claims description 7
- 235000014826 Mangifera indica Nutrition 0.000 claims description 7
- 235000009184 Spondias indica Nutrition 0.000 claims description 7
- 235000020233 pistachio Nutrition 0.000 claims description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 6
- 239000002574 poison Substances 0.000 claims description 6
- 231100000614 poison Toxicity 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 240000001900 Schleichera oleosa Species 0.000 claims description 5
- 235000010236 Schleichera oleosa Nutrition 0.000 claims description 5
- 241000065610 Cotinus Species 0.000 claims description 4
- 244000194101 Ginkgo biloba Species 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 241001244799 Gluta usitata Species 0.000 claims description 4
- 240000003152 Rhus chinensis Species 0.000 claims description 4
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 4
- 240000003935 Sclerocarya birrea Species 0.000 claims description 4
- 235000001836 Sclerocarya caffra Nutrition 0.000 claims description 4
- 241000871335 Semecarpus anacardium Species 0.000 claims description 4
- 235000018087 Spondias lutea Nutrition 0.000 claims description 4
- 241000249058 Anthracothorax Species 0.000 claims description 3
- 241000219492 Quercus Species 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000011201 Ginkgo Nutrition 0.000 claims 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical class CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 2
- 244000127759 Spondias lutea Species 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 20
- 206010012442 Dermatitis contact Diseases 0.000 abstract description 6
- 238000000638 solvent extraction Methods 0.000 abstract description 6
- 208000002029 allergic contact dermatitis Diseases 0.000 abstract description 4
- 238000010898 silica gel chromatography Methods 0.000 abstract description 3
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 229960001866 silicon dioxide Drugs 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 24
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 22
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 18
- 238000009169 immunotherapy Methods 0.000 description 14
- 239000000039 congener Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 229910052938 sodium sulfate Inorganic materials 0.000 description 10
- 235000011152 sodium sulphate Nutrition 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 9
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- 244000226021 Anacardium occidentale Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- DXRKLUVKXMAMOV-UHFFFAOYSA-N 3-heptadecylcatechol Chemical compound CCCCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DXRKLUVKXMAMOV-UHFFFAOYSA-N 0.000 description 5
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 5
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 5
- 240000007228 Mangifera indica Species 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 235000003484 annual ragweed Nutrition 0.000 description 5
- 235000006263 bur ragweed Nutrition 0.000 description 5
- 235000003488 common ragweed Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 235000009736 ragweed Nutrition 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 235000003447 Pistacia vera Nutrition 0.000 description 4
- 239000013566 allergen Substances 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 244000063498 Spondias mombin Species 0.000 description 2
- 244000044283 Toxicodendron succedaneum Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- -1 urushiol catechols Chemical class 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- VNRWRBJKPUBFDY-UHFFFAOYSA-N 2-(1,3-thiazol-4-yl)ethanamine Chemical compound NCCC1=CSC=N1 VNRWRBJKPUBFDY-UHFFFAOYSA-N 0.000 description 1
- 108700032051 Ambrosia artemisiifolia Amb a I Proteins 0.000 description 1
- 241000693997 Anacardium Species 0.000 description 1
- 235000001271 Anacardium Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000858129 Toxicodendron diversilobum Species 0.000 description 1
- 241001639798 Toxicodendron pubescens Species 0.000 description 1
- 241000871311 Toxicodendron vernix Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 208000028004 allergic respiratory disease Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- HIRGQGZZYOYRGV-UHFFFAOYSA-N chloroform;pentane Chemical compound ClC(Cl)Cl.CCCCC HIRGQGZZYOYRGV-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- ARFLASKVLJTEJD-UHFFFAOYSA-N ethyl 2-bromopropanoate Chemical compound CCOC(=O)C(C)Br ARFLASKVLJTEJD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000000534 ion trap mass spectrometry Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229940065004 poison ivy extract Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000004335 respiratory allergy Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YVVZLCSLKDOVDK-UHFFFAOYSA-N trimethoxy-[4-(1,3-thiazol-5-yl)butyl]silane Chemical compound CO[Si](OC)(OC)CCCCC1=CN=CS1 YVVZLCSLKDOVDK-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
- C07C35/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings with more than one hydroxy group bound to the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Definitions
- the disclosure relates generally to the field of immunology and allergic reactions.
- Poison ivy is one of the most medically problematic plants, and is responsible for causing allergic contact dermatitis in humans. It has been estimated that approximately 85% of the US population is sensitized to these plants. While the chemistry of the allergen and the immunologic mechanism of the reaction are different, both clinical experience and animal studies suggest that poison ivy, like respiratory allergy to ragweed, should be responsive to injection immunotherapy.
- Ragweed allergen was identified and quantitated in the 1960's and its safe and effective immunotherapy doses identified in dose ranging studies in the 1960‘s and’70's. Immunotherapy has the prospective ability to lessen the abnormal immunological responses to an allergen. Double blind immunotherapy discontinuation studies of ragweed have shown that even after a full year patients show no symptoms of response to the plant. There are no known studies to validate human injection immunotherapy or identify safe and effective treatment doses and schedules for poison ivy allergies.
- Urushiol is an oily organic allergen found in plants in the family Anacardiaceae. Notable plants includes cashew (in the type genus Anacardium ), mango, pistachio, poison ivy (e.g., Toxicodendron radicans ), poison oak (e.g., Toxicodendron diversilobum and Toxicodendron pubescens ), sumac, smoke tree, marula, yellow mombin, and cuachalalate. It has been demonstrated that the heteroolefinic components of the urushiols contained in the plants within this family are not identical in structure or composition.
- urushiol as used herein includes mixtures of heteroolefinic catechols of Anacardiaceae plants, e. g., poison ivy, poison oak, cashew, pistachio, or mango, as well as to individual components of such mixtures.
- Urushiol is a mixture 3-n-alk-(en)-yl catechols with varying degrees of unsaturation on either the C 15 side chain (derived from poison ivy chain) or C 17 side chain (derived from poison oak), often including those shown in FIG. 1 . Conclusive identification of the structure was first made in 1934; purification yielded a yellow oil with a boiling point of 210 degrees Celsius. Urushiol primarily resides in resin canals, present in the leaves, flowers, roots, bark and fruits of the plant. In addition to poison oak, poison ivy, and poison sumac, other urushiol-containing plants in this family are the Chinese and Japanese lac trees ( R.
- T-cell receptors may be directed against the side chain, with the di-saturated and tri-saturated chains producing the majority of the immunological response. Yet due to the hydrophobic nature of the molecule, the alkyl side chain should be buried within the membrane leaving the catechol ring near the surface. Therefore it is difficult to theorize how the side chain could move out of the membrane and have an effect upon immunological response.
- One proposed mechanism attributes it to a membrane vesicle. Alternatively T-cell reaction could be against the catechol ring, and increasing reactivity with unsaturated side chains could be due to an altered presentation of the catechol ring.
- This disclosure relates to a method for preparing a concentrated urushiol extraction of a plant, comprising soaking materials from the plant in at least one primary organic solvent selected from the group consisting of methylene chloride, isopropanol, tetrahydrofuran (THF), dichloromethane (DCM), acetonitrile, dimethoxyethane, propanol, chloroform, and pentane, or combinations of these, filtering out the plant materials forming an initial extract, removing the primary solvent from the initial extract forming a crude extract, combing the crude extract with hexane forming a resuspension, extracting the resuspension with acetonitrile forming an acetonitrile fraction and a depleted fraction, and removing acetonitrile from the acetonitrile fraction producing a concentrated urushiol extract.
- methylene chloride isopropanol, tetrahydrofuran (
- the plant can be selected from the group consisting of cashews, pistachios, mangos, poison ivies, poison oaks, sumacs, smoke trees, marulas, yellow mombins, cuachalalates, lac trees, rengus tree, Burmese lacquer tree, India marking nut tree, ginkgo biloba , and combination of these.
- the materials from the plant may be leaves, stems, bark, or shells.
- the materials from the plant can be shredded before soaking in the primary solvent.
- the soaking of materials from the plant may also including actively mixing (e.g., stirring or shaking) the materials and the primary solvent.
- the extraction method or portions of it are preferably performed at or below 30 degree Celsius.
- the disclosure herein also relates to a method for preparing a concentrated urushiol extraction of a plant. That method includes fractioning an urushiol preparation using a thiazole-derivatized chromatography medium, such as a thiazole-derivatized silica gel (a “thiazole silica gel”). Fractionating with thiazole silica gel involves contacting an urushiol preparation with thiazole silica gel, and eluting urushiol therefrom using chloroform (e.g., by applying to the gel a fluid having an increasing proportion of chloroform over time). The fractionating with thiazole silica gel may be performed at a sub-atmospheric pressure, such as under ordinary laboratory “vacuum” conditions.
- the disclosure also relates to a highly purified urushiol extract of a plant having a purity of more than 96% (w/w).
- the highly pure urushiol extract may be produced and purified by the aforementioned methods.
- FIG. 1 is a series of chemical structures of urushiol congeners that occur in poison ivy and poison oak.
- Individual congeners that are shown include, for poison ivy: 1 a is pentadecyl catechol (PDC), 1 b is monounsaturated (8-9) PDC, 1 c is diunsaturated (8-9, 11-12) PDC, and 1 d is triunsubstituted (8-9, 11-12, 14-15) PDC: and for poison oak: 2 a is heptadecyl catechol (HDC), 2 b is monounsaturated (8-9) HDC, 2 c is diunsaturated (8-9, 11-12) HDC, and 2 d is triunsubstituted (8-9, 11-12, 14-15) HDC.
- PDC pentadecyl catechol
- 1 b monounsaturated (8-9) PDC
- 1 c is diunsaturated (8-9, 11-12) PDC
- FIG. 2 illustrates a previously described method of preparing urushiol.
- FIG. 3 illustrates a method described herein for preparing urushiol, using methylene chloride as the primary solvent.
- FIG. 4 is a gas chromatograph profile of a poison ivy urushiol extract prepared as described herein.
- FIG. 5 is a graph that illustrates stability over time of a poison ivy urushiol extract prepared as described herein. Diamonds represent samples stored at 3 degrees Celsius, and squares represent samples stored at 23 degrees Celsius.
- the disclosure relates to methods of preparing urushiol and related compounds from botanical sources such as plants of the Anacardiaceae family, including poison ivy and poison oak.
- this disclosure relates to extraction of urushiol to produce a substantially purified urushiol product, including products suitable to diagnose and treat allergic contact dermatitis, such as that resulting from contact with poison ivy or poison oak, or suitable for use as a vaccine or immunotherapy agent.
- the term “vaccine” or “allergy vaccine” refers to a compound that can induce tolerance to undesirable cell-mediated immunity conditions, such as allergic contact dermatitis.
- the methods described herein can be adapted for extraction of urushiol from plants of the family Anacardiaceae and from other plants, such as cashew, pistachio, mango, Rengus tree, Burmese lacquer tree, India marking nut tree, and the shell of the cashew nut, as well as ginkgo biloba.
- urushiol catechols have an unsaturated side chain and these catechols are believed to be progressively less stable than the saturated fourth component, 3-n-pentadecyl catechol, and thus more prone to polymerization and oxidation reactions as the degree of unsaturation in the side chain increases from one to three olefinic bonds.
- Aged samples of urushiol have variable compositions of these unsaturated components along with their polymers and oxidation products, depending upon the degree of prior exposure to air, water, and light, as well as the presence of acidic or basic conditions and elevated temperatures.
- Unsaturated components of urushiol show a tendency to polymerize under acidic conditions and to oxidize under aerobic conditions, with oxidation being accelerated in an alkaline environment. These reactions lead to products of a polymeric nature and with a loss in aromaticity. For these reasons, elevated temperatures and exposure to air should be avoided during the extraction process. It is also advisable to use freshly collected raw materials when extracting urushiol from plant sources.
- the methods of preparing urushiol described herein include extraction with a primary organic solvent to form an initial extract, stripping the primary solvent from the initial extract to yield a crude extract and prior to solvent extraction using a mixture of a more-polar first solvent and a less-polar second solvent that are substantially immiscible with one another under the extraction conditions used (e.g., hexane and acetonitrile used at a temperature ⁇ 30 degrees Celsius).
- extraction conditions used e.g., hexane and acetonitrile used at a temperature ⁇ 30 degrees Celsius.
- the primary solvent should be less polar, and preferably more hydrophobic, than ethanol.
- a few relatively hydrophilic solvents e.g., acetonitrile and tetrahydrofuran
- suitably non-polar and hydrophobic solvents include methylene chloride, isopropanol, dichloromethane, dimethoxyethane, propanol, chloroform, pentane, and mixtures of these.
- FIG. 3 An example of the preparative method using methylene chloride as the primary solvent is shown in FIG. 3 .
- the primary solvent used in the initial extraction is removed by evaporation to yield the crude extract.
- the crude extract is resuspended in hexane (or another aliphatic hydrocarbon solvent) and acetonitrile. Because those two solvents are immiscible under the conditions used, materials in the crude extract can partition between the immiscible solvent phases.
- the urushiol extract from the acetonitrile fraction can then be concentrated, and acetonitrile removed by evaporation, forming a concentrated urushiol extract.
- the concentrated urushiol extract can then be resuspended in a suitable solvent, such as ethyl alcohol, and stored. Concentrated urushiol can be separated into congeners by means of high pressure liquid chromatography or other similar methods, if desired.
- processing steps were performed at room temperature (i.e., ca. 20 degrees Celsius).
- the preparative procedures are preferably performed at temperatures below 30 degree Celsius.
- the ElSohly method includes multiple steps, including ethanol extraction of poison ivy leaves, followed by chloroform/water fractionation, dry-packed silica-gel column chromatography, and hexane/acetonitrile partitioning.
- the extraction methods disclosed herein have the advantage of utilizing a single primary solvent and fewer overall steps. Use of single solvents can avoid toxicity in humans.
- the methods described herein also can achieve higher yield and purity with fewer purification steps than prior methods, and improve the stability of the extraction products.
- the methods described herein typically provide yields of urushiol in the range of 1.33-1.43 grams per kilogram of raw material (i.e., a 0.133-0.143% (w/w) yield).
- the purity of the urushiol prepared according to the method disclosed herein was higher, as determined by gas chromatography-mass spectrometric (GCMS) analysis, than the reported purity of urushiol extract using the ElSohly method.
- the high purity urushiol extract obtained by the methods disclosed herein is indicated by the gas chromatography profile shown in FIG. 4 .
- the concentration of urushiol prepared according to the methods disclosed herein is higher than previously achievable.
- the ElSohly method has been demonstrated to yield an urushiol extract having a concentration not greater than about 2 milligram per milliliter.
- the concentration of urushiol in extracts made using the process described herein was shown to be upwards of 50 milligram per milliliter.
- urushiol preparations such as reagents for immunologic treatment of humans who experience allergic reactions upon contact with poison ivy or poison oak.
- Effective treatment depends heavily upon the sensitivity of the individual seeking treatment and the concentration and purity of urushiol concentrations that are available for treatment. As the individual's sensitivity to urushiol decreases, more urushiol is needed to elicit a desired degree of reaction and a higher dose of urushiol extract is needed to achieve successful immunotherapy treatment.
- a higher dose must come from a higher concentration of urushiol in the extract, and not from simply increasing the volume of the urushiol extract, because there are physiological limits to the quantity of reagent that can be effectively delivered to a patient. It is therefore preferable to use immunotherapy agents having high urushiol concentration and low solvent content.
- the high concentration urushiol that can be prepared using the methods described herein facilitate immunological treatment of people who exhibit moderate or low sensitivity to poison ivy or poison oak.
- the urushiol preparation obtained using the methods described herein permits a much higher amount of urushiol to be practically applied in order to elicit an allergic response in these patients.
- the urushiol extract prepared as described herein can be further purified by chromatography, if desired.
- a preferred chromatographic method is liquid chromatography employing a bed packed with a thiazole-derivatized medium, such as the thiazole silica gel described in the examples herein.
- Thiazole silica gel can be prepared by reacting a silica gel by reacting with a thiazole compound, for example, 5-(4-(trimethoxysilyl)butyl)thiazole.
- the thiazole silica gel may be dry-packed in a column using known methods.
- An urushiol sample can be applied to the dry-packed thiazole silica column and eluted therefrom by passing over the column packing a solvent that includes a solvent (e.g., chloroform) that will displace urushiol from the thiazole-derivatized medium.
- a solvent e.g., chloroform
- the chloroform or other solvent can thereafter be removed by evaporation. If necessary or desired, trace amount of chloroform or other solvent can be removed by ether distillation.
- thiazole-modified silica gel enhances purification efficiency.
- Urushiol extract can be purified using thiazole silica gel chromatography to a purity greater than 96% by weight (ignoring solvent) or higher, for example, above 97%, above 98%, or above 99%.
- Table 1 summarizes examples of urushiol preparations from poison ivy leaves that were performed as described herein. Examples 2-10 illustrate the methods described in this disclosure and generally exhibited higher yield and greater urushiol concentration than the ElSohly method.
- Relative congener concentration can also vary with the identity and treatment of plant raw materials used in the extraction (for example, the plant age, the season or time of year collected, and the plants' specific growth conditions).
- the monounsaturated urushiol was in highest concentration ( ⁇ 43%), averages of percentage concentration varying statistically insignificantly among different extractions but having a relatively high standard deviation within each data set (as high as ⁇ 11% for pentane extractions) (Table 2).
- Urushiol in preparations made as described herein have shown remarkable stability. Urushiol is stable at a concentration of 50 milligram per milliliter in ethanol.
- FIG. 5 shows the stability of an urushiol extract prepared using methylene chloride as the primary solvent. Samples were tested up to 250 days stored at 3 degrees Celsius (Diamonds) and 23 degrees Celsius (Squares). No significant difference was observed over the time period for either set of stored samples.
- vaccines can be prepared that are suitable to induce tolerance in patients with significant clinical disease, but with relatively low levels of pre-treatment patch-test sensitivity. Both clinical tolerance to natural exposure and reduction in patch test sensitivity have lasted nine months or more using such vaccines. These vaccines are believed to be the first to induce long-lasting tolerance to urushiol in previously sensitized humans.
- Poison ivy ( Toxicodendron radicans ) leaves were collected in June, July and August 2011 in a forest located in Mantua, N.J. The leaves were stored in a refrigerator substantially immediately after harvest and used for extraction within 7-10 days. Freshly collected poison ivy raw material (leaves and stems) was torn by hand only to the extent that each leaf was torn at least once before solvent extraction. It is expected that more thorough shredding of such materials will enhance extraction yield.
- Poison ivy leaves (30 grams) were soaked in 100% ethanol (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent on a rotary evaporator. GCMS analysis showed approximately 42% w/w urushiol. The resulting dark green residue was then resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed on a rotary evaporator with temperature between 20 and 30 degrees Celsius to yield a residue.
- Poison ivy leaves (30 grams) were soaked in 1:1 isopropanol:THF (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 32% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed on a rotary evaporator at a temperature between 20 and 30 degree Celsius to yield a residue.
- Poison ivy leaves 35 grams were soaked in THF (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 31% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degree Celsius to yield a residue.
- Poison ivy leaves 32 grams were soaked in acetonitrile (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction device. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at temperature between 20 and 30 degree Celsius to yield a residue.
- the residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Poison ivy leaves 60 grams were soaked in dimethoxyethane (400 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was then resuspended in 100 milliliters ether and washed thrice with water. The organic fractions were dried over sodium sulfate (20 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue.
- Poison ivy leaves 60 grams were soaked in propanol (400 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters ether and washed thrice with water. The organic fractions were dried over sodium sulfate (20 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue.
- the residue was fractionated by column chromatography (25 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Poison ivy leaves 35 grams were soaked in 150 milliliters of chloroform for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 30% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction device. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue.
- Poison ivy leaves (40 grams) were soaked in 200 milliliters of pentane for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent on a rotary evaporator. GCMS analysis showed approximately 42.4% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction process. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to afford a residue.
- the residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Silica 25 grams was suspended in 200 milliliters of dry toluene before adding 10 milliliters of 3-aminopropyltriethoxysilane. The mixture was stirred and refluxed for 24 hours under a nitrogen atmosphere. The resulting product was filtered and washed twice with 50 milliliters of toluene, twice with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane. The product was dried for 6 hours at room temperature under laboratory vacuum, and then immersed in 200 milliliters of toluene prior to adding 6.25 milliliters of ethyl-2-bromopropionate. The mixture was again stirred and refluxed for 24 hours under a nitrogen atmosphere.
- the resulting product was filtered and washed twice with 50 milliliters of toluene, four times with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane.
- the resulting product was dried for 6 hours at room temperature under laboratory vacuum, dispersed in 200 milliliters of dry acetonitrile, and then 8.3 grams of 2-(thiazol-4-yl)ethanamine was added. The mixture was stirred and refluxed for 24 hours under a nitrogen atmosphere.
- the product was filtered and washed twice with 50 milliliters of acetonitrile, six times with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane. This final product was dried at room temperature under vacuum to yield a thiazole silica gel.
- Urushiol congeners were separated as follows. An absorbance spectrum was obtained using purified extract showing maximum absorbance at 276 nanometers. High pressure liquid chromatography analysis was run on a C18 reverse phase column, and individual urushiol congener peaks were assessed by mass spectrometry (MS). Dried poison ivy urushiol was dissolved in ethanol and eluted with a 60 to 100% methanol gradient. Samples were collected and analyzed by MS. Preparative separation of urushiol components of the purified poison ivy extract was performed by reverse phase preparatory FPLC.
- Urushiol extract prepared using methylene chloride as the primary solvent was transferred into a round bottom flask and stripped of solvent using a rotary evaporator to near dryness.
- a sample taken therefrom for GCMS analysis which indicated the presence of hexane and methylene chloride in the sample.
- the extract was thrice resuspended in approximately 150 milliliters of diethyl ether and stripped of solvent. Following resuspension in ethanol, the product contained no detectable amount of hexane or methylene chloride.
- High Pressure Liquid Chromatography (HPLC) analysis was run on C18 reversed phase column, to determine individual urushiol congener peaks by mass spectrometry on a Agilent Model 1100 LC-MS System. Dried poison ivy urushiol was dissolved in ethanol and eluted with a 60 to 100% methanol gradient. Samples were collected and analyzed by ion-trap mass spectrometry.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
- The disclosure relates generally to the field of immunology and allergic reactions.
- Poison ivy is one of the most medically problematic plants, and is responsible for causing allergic contact dermatitis in humans. It has been estimated that approximately 85% of the US population is sensitized to these plants. While the chemistry of the allergen and the immunologic mechanism of the reaction are different, both clinical experience and animal studies suggest that poison ivy, like respiratory allergy to ragweed, should be responsive to injection immunotherapy. Ragweed allergen was identified and quantitated in the 1960's and its safe and effective immunotherapy doses identified in dose ranging studies in the 1960‘s and’70's. Immunotherapy has the prospective ability to lessen the abnormal immunological responses to an allergen. Double blind immunotherapy discontinuation studies of ragweed have shown that even after a full year patients show no symptoms of response to the plant. There are no known studies to validate human injection immunotherapy or identify safe and effective treatment doses and schedules for poison ivy allergies.
- Urushiol is an oily organic allergen found in plants in the family Anacardiaceae. Notable plants includes cashew (in the type genus Anacardium), mango, pistachio, poison ivy (e.g., Toxicodendron radicans), poison oak (e.g., Toxicodendron diversilobum and Toxicodendron pubescens), sumac, smoke tree, marula, yellow mombin, and cuachalalate. It has been demonstrated that the heteroolefinic components of the urushiols contained in the plants within this family are not identical in structure or composition. The term urushiol as used herein includes mixtures of heteroolefinic catechols of Anacardiaceae plants, e. g., poison ivy, poison oak, cashew, pistachio, or mango, as well as to individual components of such mixtures.
- Urushiol is a mixture 3-n-alk-(en)-yl catechols with varying degrees of unsaturation on either the C15 side chain (derived from poison ivy chain) or C17 side chain (derived from poison oak), often including those shown in
FIG. 1 . Conclusive identification of the structure was first made in 1934; purification yielded a yellow oil with a boiling point of 210 degrees Celsius. Urushiol primarily resides in resin canals, present in the leaves, flowers, roots, bark and fruits of the plant. In addition to poison oak, poison ivy, and poison sumac, other urushiol-containing plants in this family are the Chinese and Japanese lac trees (R. verniciflua L.) and the Yunnan, Formosan and Indo-Chinese lac trees (R. succedanea L.). Agriculturally significant Mango (M. indica), Cashew (A. occidentale), and Pistachio (P. vera) trees also contain urushiol. - The long aliphatic side chains of these catechols cause the molecules to be hydrophobic, making urushiol one of the most lipophilic haptens that cause contact dermatitis. As a result of this lipophilicity urushiol tends to concentrate in cellular membranes. Upon contact with human tissue, the catechol ring undergoes oxidation, forming an electrophilic o-quinone. This undergoes a regiospecific attack by model sulfhydryl and amino nucleophiles present on proteins to form the adduct. However, the lack of covalent bonding between urushiol and cell membranes used for introduction into cultures makes the mechanism of antigen presentation unclear.
- In vivo experiments suggest that T-cell receptors may be directed against the side chain, with the di-saturated and tri-saturated chains producing the majority of the immunological response. Yet due to the hydrophobic nature of the molecule, the alkyl side chain should be buried within the membrane leaving the catechol ring near the surface. Therefore it is difficult to theorize how the side chain could move out of the membrane and have an effect upon immunological response. One proposed mechanism attributes it to a membrane vesicle. Alternatively T-cell reaction could be against the catechol ring, and increasing reactivity with unsaturated side chains could be due to an altered presentation of the catechol ring.
- Immunotherapy with water-soluble ragweed antigen E has been shown to not only prevent reactions on natural exposure during immunotherapy but also to provide durable protection for at least a year after stopping treatment. Double blind immunotherapy discontinuation studies of ragweed have shown that, even after a full year, patients show no symptoms of response to the antigen. Based on immunological studies of ragweed, it was hypothesized that urushiol can be extracted and used in immunotherapy against contact dermatitis. However, previous extraction methods have proven difficult and inefficient, being multi-stepped and involving multiple solvents. The most common technique used by others involves soaking plant material in ethanol followed by distillation or dry packed silica column chromatography. Urushiol congeners can be separated using HPLC if desired. An example of an urushiol extraction method (hereinafter the “ElSohly method”) described by ElSohly et al. (J. Nat. Prod., 1982, 45(5):532-538) in summarized in
FIG. 2 . - The ElSohly method and other multiple-solvent purification methods have shortfalls, including use of undesirably large quantities of solvents, restriction to small (volumetric) scale processing, and low yields. Limitations of crude ethanol extracts as allergy vaccines include limited storage stability and urushiol concentrations insufficient for effective treatment of moderately sensitive individuals.
- Crude ethanol extracts having urushiol concentrations up to 1-2 milligram per milliliter have been described. (Coifman R E, “Successful immunotherapy for poison ivy,” presented to 2010 Annual Meeting of the American Academy of Allergy Asthma & Immunology, New Orleans La., 28 Feb. 2010 (Abs. 142), epub J. Allerg. Clin. Immunol. 2010 (February)).
- A need exists for improved methods for extraction of urushiol from plant materials at concentrations and purity levels suitable for immunotherapy or other treatment of hypersensitivity.
- This disclosure relates to a method for preparing a concentrated urushiol extraction of a plant, comprising soaking materials from the plant in at least one primary organic solvent selected from the group consisting of methylene chloride, isopropanol, tetrahydrofuran (THF), dichloromethane (DCM), acetonitrile, dimethoxyethane, propanol, chloroform, and pentane, or combinations of these, filtering out the plant materials forming an initial extract, removing the primary solvent from the initial extract forming a crude extract, combing the crude extract with hexane forming a resuspension, extracting the resuspension with acetonitrile forming an acetonitrile fraction and a depleted fraction, and removing acetonitrile from the acetonitrile fraction producing a concentrated urushiol extract.
- The plant can be selected from the group consisting of cashews, pistachios, mangos, poison ivies, poison oaks, sumacs, smoke trees, marulas, yellow mombins, cuachalalates, lac trees, rengus tree, Burmese lacquer tree, India marking nut tree, ginkgo biloba, and combination of these. The materials from the plant may be leaves, stems, bark, or shells.
- The materials from the plant can be shredded before soaking in the primary solvent. The soaking of materials from the plant may also including actively mixing (e.g., stirring or shaking) the materials and the primary solvent.
- The extraction method or portions of it are preferably performed at or below 30 degree Celsius.
- The disclosure herein also relates to a method for preparing a concentrated urushiol extraction of a plant. That method includes fractioning an urushiol preparation using a thiazole-derivatized chromatography medium, such as a thiazole-derivatized silica gel (a “thiazole silica gel”). Fractionating with thiazole silica gel involves contacting an urushiol preparation with thiazole silica gel, and eluting urushiol therefrom using chloroform (e.g., by applying to the gel a fluid having an increasing proportion of chloroform over time). The fractionating with thiazole silica gel may be performed at a sub-atmospheric pressure, such as under ordinary laboratory “vacuum” conditions.
- The disclosure also relates to a highly purified urushiol extract of a plant having a purity of more than 96% (w/w). The highly pure urushiol extract may be produced and purified by the aforementioned methods.
-
FIG. 1 is a series of chemical structures of urushiol congeners that occur in poison ivy and poison oak. Individual congeners that are shown include, for poison ivy: 1 a is pentadecyl catechol (PDC), 1 b is monounsaturated (8-9) PDC, 1 c is diunsaturated (8-9, 11-12) PDC, and 1 d is triunsubstituted (8-9, 11-12, 14-15) PDC: and for poison oak: 2 a is heptadecyl catechol (HDC), 2 b is monounsaturated (8-9) HDC, 2 c is diunsaturated (8-9, 11-12) HDC, and 2 d is triunsubstituted (8-9, 11-12, 14-15) HDC. -
FIG. 2 illustrates a previously described method of preparing urushiol. -
FIG. 3 illustrates a method described herein for preparing urushiol, using methylene chloride as the primary solvent. -
FIG. 4 is a gas chromatograph profile of a poison ivy urushiol extract prepared as described herein. -
FIG. 5 is a graph that illustrates stability over time of a poison ivy urushiol extract prepared as described herein. Diamonds represent samples stored at 3 degrees Celsius, and squares represent samples stored at 23 degrees Celsius. - The disclosure relates to methods of preparing urushiol and related compounds from botanical sources such as plants of the Anacardiaceae family, including poison ivy and poison oak. In particular, this disclosure relates to extraction of urushiol to produce a substantially purified urushiol product, including products suitable to diagnose and treat allergic contact dermatitis, such as that resulting from contact with poison ivy or poison oak, or suitable for use as a vaccine or immunotherapy agent.
- Within the context of this disclosure, the term “vaccine” or “allergy vaccine” refers to a compound that can induce tolerance to undesirable cell-mediated immunity conditions, such as allergic contact dermatitis. The methods described herein can be adapted for extraction of urushiol from plants of the family Anacardiaceae and from other plants, such as cashew, pistachio, mango, Rengus tree, Burmese lacquer tree, India marking nut tree, and the shell of the cashew nut, as well as ginkgo biloba.
- Three urushiol catechols have an unsaturated side chain and these catechols are believed to be progressively less stable than the saturated fourth component, 3-n-pentadecyl catechol, and thus more prone to polymerization and oxidation reactions as the degree of unsaturation in the side chain increases from one to three olefinic bonds. Aged samples of urushiol have variable compositions of these unsaturated components along with their polymers and oxidation products, depending upon the degree of prior exposure to air, water, and light, as well as the presence of acidic or basic conditions and elevated temperatures.
- Unsaturated components of urushiol show a tendency to polymerize under acidic conditions and to oxidize under aerobic conditions, with oxidation being accelerated in an alkaline environment. These reactions lead to products of a polymeric nature and with a loss in aromaticity. For these reasons, elevated temperatures and exposure to air should be avoided during the extraction process. It is also advisable to use freshly collected raw materials when extracting urushiol from plant sources.
- The methods of preparing urushiol described herein include extraction with a primary organic solvent to form an initial extract, stripping the primary solvent from the initial extract to yield a crude extract and prior to solvent extraction using a mixture of a more-polar first solvent and a less-polar second solvent that are substantially immiscible with one another under the extraction conditions used (e.g., hexane and acetonitrile used at a temperature<30 degrees Celsius).
- The primary solvent should be less polar, and preferably more hydrophobic, than ethanol. However, a few relatively hydrophilic solvents (e.g., acetonitrile and tetrahydrofuran) can yield acceptable results Examples of suitably non-polar and hydrophobic solvents include methylene chloride, isopropanol, dichloromethane, dimethoxyethane, propanol, chloroform, pentane, and mixtures of these.
- An example of the preparative method using methylene chloride as the primary solvent is shown in
FIG. 3 . In that method, the primary solvent used in the initial extraction is removed by evaporation to yield the crude extract. The crude extract is resuspended in hexane (or another aliphatic hydrocarbon solvent) and acetonitrile. Because those two solvents are immiscible under the conditions used, materials in the crude extract can partition between the immiscible solvent phases. The urushiol extract from the acetonitrile fraction can then be concentrated, and acetonitrile removed by evaporation, forming a concentrated urushiol extract. The concentrated urushiol extract can then be resuspended in a suitable solvent, such as ethyl alcohol, and stored. Concentrated urushiol can be separated into congeners by means of high pressure liquid chromatography or other similar methods, if desired. - In the methods used in the examples described herein, processing steps were performed at room temperature (i.e., ca. 20 degrees Celsius). The preparative procedures are preferably performed at temperatures below 30 degree Celsius.
- The ElSohly method includes multiple steps, including ethanol extraction of poison ivy leaves, followed by chloroform/water fractionation, dry-packed silica-gel column chromatography, and hexane/acetonitrile partitioning. The extraction methods disclosed herein have the advantage of utilizing a single primary solvent and fewer overall steps. Use of single solvents can avoid toxicity in humans. The methods described herein also can achieve higher yield and purity with fewer purification steps than prior methods, and improve the stability of the extraction products. The methods described herein typically provide yields of urushiol in the range of 1.33-1.43 grams per kilogram of raw material (i.e., a 0.133-0.143% (w/w) yield).
- The purity of the urushiol prepared according to the method disclosed herein was higher, as determined by gas chromatography-mass spectrometric (GCMS) analysis, than the reported purity of urushiol extract using the ElSohly method. The high purity urushiol extract obtained by the methods disclosed herein is indicated by the gas chromatography profile shown in
FIG. 4 . Furthermore, the concentration of urushiol prepared according to the methods disclosed herein is higher than previously achievable. The ElSohly method has been demonstrated to yield an urushiol extract having a concentration not greater than about 2 milligram per milliliter. The concentration of urushiol in extracts made using the process described herein was shown to be upwards of 50 milligram per milliliter. - These improved characteristics are highly relevant to important intended uses of urushiol preparations, such as reagents for immunologic treatment of humans who experience allergic reactions upon contact with poison ivy or poison oak. Effective treatment depends heavily upon the sensitivity of the individual seeking treatment and the concentration and purity of urushiol concentrations that are available for treatment. As the individual's sensitivity to urushiol decreases, more urushiol is needed to elicit a desired degree of reaction and a higher dose of urushiol extract is needed to achieve successful immunotherapy treatment. A higher dose must come from a higher concentration of urushiol in the extract, and not from simply increasing the volume of the urushiol extract, because there are physiological limits to the quantity of reagent that can be effectively delivered to a patient. It is therefore preferable to use immunotherapy agents having high urushiol concentration and low solvent content.
- The high concentration urushiol that can be prepared using the methods described herein facilitate immunological treatment of people who exhibit moderate or low sensitivity to poison ivy or poison oak. The urushiol preparation obtained using the methods described herein permits a much higher amount of urushiol to be practically applied in order to elicit an allergic response in these patients.
- The urushiol extract prepared as described herein can be further purified by chromatography, if desired. A preferred chromatographic method is liquid chromatography employing a bed packed with a thiazole-derivatized medium, such as the thiazole silica gel described in the examples herein. Thiazole silica gel can be prepared by reacting a silica gel by reacting with a thiazole compound, for example, 5-(4-(trimethoxysilyl)butyl)thiazole. The thiazole silica gel may be dry-packed in a column using known methods. An urushiol sample can be applied to the dry-packed thiazole silica column and eluted therefrom by passing over the column packing a solvent that includes a solvent (e.g., chloroform) that will displace urushiol from the thiazole-derivatized medium. The chloroform or other solvent can thereafter be removed by evaporation. If necessary or desired, trace amount of chloroform or other solvent can be removed by ether distillation.
- Compared to the unmodified silica gel used in the ElSohly method, thiazole-modified silica gel enhances purification efficiency. Urushiol extract can be purified using thiazole silica gel chromatography to a purity greater than 96% by weight (ignoring solvent) or higher, for example, above 97%, above 98%, or above 99%.
- Table 1 summarizes examples of urushiol preparations from poison ivy leaves that were performed as described herein. Examples 2-10 illustrate the methods described in this disclosure and generally exhibited higher yield and greater urushiol concentration than the ElSohly method.
- Comparison of gas chromatography peak distributions and relative abundances the effect of varying extraction routes on relative congener/isomer concentrations, as shown in Table 2. Relative congener concentration can also vary with the identity and treatment of plant raw materials used in the extraction (for example, the plant age, the season or time of year collected, and the plants' specific growth conditions). In all performed extraction routes the monounsaturated urushiol was in highest concentration (˜43%), averages of percentage concentration varying statistically insignificantly among different extractions but having a relatively high standard deviation within each data set (as high as ±11% for pentane extractions) (Table 2). The next most prominent congener (11-25%) was the di-unsaturated urushiol which varied among the different extractions (Table 2). The fully saturated congener, was present in less concentration (5-6%) without variation among reactions (Table 2). The final urushiol congener, the thrice disaturated molecule was present in nearly undetectable levels throughout all extracts (1-3%) (Table 2). Ethoxy derivatives of urushiol as well as E/Z isomers varied significantly among extractions suggesting their levels are greatly dependent on the technique and care used during the purification, as well as age and other factors.
-
TABLE 1 Summary of Examples of Poison Ivy Urushiol Extraction and Purification Total Poison Ivy Leaf Crude Purity Acetonitrile Weight Final Purity Example Primary Solvent Steps Weight (g) (wt %) Fraction Purity (wt %) (g) (wt %) 1 Ethanol 5 30 42 ~42 0.25 90 2 Methylene Chloride 3 90 58 58 0.62 99.5 3 Isopropanol/THF 3 30 32 92 0.35 98 4 DCM/THF 3 29 30 90 0.30 N/A 5 THF 3 35 35 93 0.36 97.5 6 Acetonitrile 3 32 34 93 0.31 96.5 7 Dimethoxyethane 3 60 34 93 0.62 98.5 8 Propanol 3 60 34 93 0.60 97.5 9 Chloroform 3 35 67 90 0.58 94.5 10 Pentane 3 40 42 86 0.39 91.5 -
TABLE 2 Peak analysis of gas chromatographs of average purified methylene chloride, chloroform and pentane extracts shown with standard deviation. Urushiol Pentane Chloroform Methylene Peak Congener (%) (%) Chloride (%) 1 1d 1.5 ± 0.9 2.7 ± 0.6 2.7 ± 0.9 2 1c 43 ± 11 43 ± 8.7 44 ± 4.0 3 1b 15 ± 2.9 25 ± 5.4 12 ± 3.8 4 1a 6.1 ± 1.1 6.5 ± 1.4 5.3 ± 0.9 5 1a 1.9 1.5 ± 0.1 2.1 ± 0.1 6 1c 3.3 ± 2.2 1.9 ± 1.2 3.2 ± 4.0 7 2c 1.5 ± 0.4 2.2 ± 1.6 3.0 ± 1.0 8 2b 4.3 ± 3.2 5.5 ± 4.0 11 ± 6 9 2a 6.5 ± 1.8 3.1 ± 0.7 9.2 ± 5.4 - Urushiol in preparations made as described herein have shown remarkable stability. Urushiol is stable at a concentration of 50 milligram per milliliter in ethanol.
FIG. 5 shows the stability of an urushiol extract prepared using methylene chloride as the primary solvent. Samples were tested up to 250 days stored at 3 degrees Celsius (Diamonds) and 23 degrees Celsius (Squares). No significant difference was observed over the time period for either set of stored samples. - Using high concentration urushiol preparations made as described herein, vaccines can be prepared that are suitable to induce tolerance in patients with significant clinical disease, but with relatively low levels of pre-treatment patch-test sensitivity. Both clinical tolerance to natural exposure and reduction in patch test sensitivity have lasted nine months or more using such vaccines. These vaccines are believed to be the first to induce long-lasting tolerance to urushiol in previously sensitized humans.
- The subject matter of this disclosure is now described with reference to the following Examples. The Examples are provided for the purpose of illustration only, and the subject matter is not limited to these Examples, but rather encompasses all variations which are evident as a result of the teaching provided herein.
- The methods described herein are illustrated in the following example. While the example involves the preparation of urushiol from poison ivy, an essentially similar procedure is followed in preparing urushiol from poison oak or from other urushiol-bearing plants.
- Plant Material
- Poison ivy (Toxicodendron radicans) leaves were collected in June, July and August 2011 in a forest located in Mantua, N.J. The leaves were stored in a refrigerator substantially immediately after harvest and used for extraction within 7-10 days. Freshly collected poison ivy raw material (leaves and stems) was torn by hand only to the extent that each leaf was torn at least once before solvent extraction. It is expected that more thorough shredding of such materials will enhance extraction yield.
- Poison ivy leaves (30 grams) were soaked in 100% ethanol (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent on a rotary evaporator. GCMS analysis showed approximately 42% w/w urushiol. The resulting dark green residue was then resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed on a rotary evaporator with temperature between 20 and 30 degrees Celsius to yield a residue. That residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) with dry packed silica gel under laboratory vacuum and eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 100 milliliters hexane. The resuspended material was thrice extracted with 100 milliliter aliquots of acetonitrile. The acetonitrile aliquots were combined and evaporated, yielding 0.25 gram of dark green oil. GCMS analysis showed 90% w/w urushiol. The concentrated extract was resuspended in ethanol and stored in refrigerator (3 degrees Celsius) in order to slow the degradation process.
- Poison ivy leaves and stems (90 grams) were soaked in methylene chloride (800 milliliters) for 4.5 hours at room temperature. The solution was filtered and stripped of solvent. GCMS analysis showed 58% w/w urushiol. The resulting dark brown oil (0.997 g) was resuspended in ethanol (100 milliliters) and dried over sodium sulfate (10 gram). The solution was then split into 3 equal volumes and each fraction was stripped of solvent. Dark brown oil (0.332 g) was resuspended in 100 milliliters hexane and extracted with acetonitrile (100 milliliters) in a Soxhlet continuous extraction apparatus. Acetonitrile fractions were collected and the solvent was evaporated to yield a green-brown oil (0.62 gram). GCMS analysis, showed 93% w/w urushiol.
- Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) with dry packed thiazole silica gel eluted with chloroform under laboratory vacuum. The purity was 99.5%. The solution was resuspended in ethanol and placed in sealed amber vials under refrigeration (3 degrees Celsius) to be formulated for clinical use.
- Poison ivy leaves (30 grams) were soaked in 1:1 isopropanol:THF (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 32% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed on a rotary evaporator at a temperature between 20 and 30 degree Celsius to yield a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium under laboratory vacuum and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 100 milliliters hexane and solvent extraction using 100 milliliters acetonitrile and a continuous extraction device. Acetonitrile fractions were combined and the solvent was evaporated therefrom, yielding 0.35 gram of dark green oil. GCMS analysis showed 92% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica gel medium under laboratory vacuum. The purity was 98%. The concentrated extract was resuspended in ethanol and stored in a refrigerator (3 degrees Celsius) in order to slow degradation.
- Poison ivy leaves (29 grams) were soaked in 1:1 dichloromethane: THF (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 30% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and extracted thrice with water using a continuous extraction device. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degree Celsius to yield a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium under laboratory vacuum and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 100 milliliters hexane followed by three rounds of solvent extraction, each round involving extraction with 100 milliliters of acetonitrile. The acetonitrile aliquots were combined and acetonitrile was evaporated therefrom, yielding 0.30 gram of dark green oil. GCMS analysis showed 90% w/w urushiol. The concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Poison ivy leaves (35 grams) were soaked in THF (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 31% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degree Celsius to yield a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium under laboratory vacuum, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 100 milliliters hexane. The resuspended material was extracted using 100 milliliters of acetonitrile in a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.36 gram of dark green oil. GCMS analysis showed 93% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica medium, and fractions were eluted with chloroform under laboratory vacuum. The purity was 97.5%. The concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Poison ivy leaves (32 grams) were soaked in acetonitrile (200 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction device. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at temperature between 20 and 30 degree Celsius to yield a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 100 milliliters hexane. The resuspended material was extracted using 100 milliliters of acetonitrile in a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.31 gram of dark green oil. GCMS analysis showed 93% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica gel medium, and fractions were eluted with chloroform under vacuum. The purity was 96.5%. The concentrated extract was resuspended in ethanol and stored in a refrigerator
- Poison ivy leaves (60 grams) were soaked in dimethoxyethane (400 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was then resuspended in 100 milliliters ether and washed thrice with water. The organic fractions were dried over sodium sulfate (20 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue. The residue was purified by column chromatography (25 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 200 milliliters hexane. The resuspended material was extracted using 100 milliliters of acetonitrile in a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.62 gram of dark green oil. GCMS analysis showed 93% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica medium, and fractions were eluted with chloroform under laboratory vacuum. The purity was 98.5%. The concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Poison ivy leaves (60 grams) were soaked in propanol (400 milliliters) for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 34% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters ether and washed thrice with water. The organic fractions were dried over sodium sulfate (20 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue. The residue was fractionated by column chromatography (25 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 200 milliliters hexane. The resuspended material was extracted with 100 milliliters of acetonitrile using a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.60 gram of dark green oil. GCMS analysis showed 93% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica gel medium, and fractions were eluted with chloroform under laboratory vacuum. The purity was 97.5%. Concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Poison ivy leaves (35 grams) were soaked in 150 milliliters of chloroform for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent using a rotary evaporator. GCMS analysis showed approximately 30% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction device. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to yield a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium under laboratory vacuum, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 200 milliliters hexane. The resuspended material was extracted with 100 milliliters of acetonitrile in a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.55 gram of dark green oil. GCMS analysis showed 91% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica gel medium, and fractions eluted with chloroform under laboratory vacuum. The purity was 94.5%. Concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Poison ivy leaves (40 grams) were soaked in 200 milliliters of pentane for approximately 4 hours at room temperature. The resulting solution was filtered to remove the leaves, collected in a round bottom flask, and stripped of solvent on a rotary evaporator. GCMS analysis showed approximately 42.4% w/w urushiol. The resulting dark green residue was resuspended in 100 milliliters chloroform and washed thrice with water using a continuous extraction process. The organic fractions were dried over sodium sulfate (10 gram) to remove traces of water. The solvent was removed using a rotary evaporator at a temperature between 20 and 30 degrees Celsius to afford a residue. The residue was fractionated by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed silica gel medium with laboratory vacuum applied, and fractions were eluted with chloroform. Fractions were collected based on color and tested for urushiol presence by a ferric chloride test and GCMS.
- Fractions that tested positive for catechol were combined, stripped of solvent, and resuspended in 200 milliliters hexane. The resuspended material was extracted with 100 milliliters acetonitrile using a continuous extraction device. Acetonitrile fractions were combined and acetonitrile was evaporated therefrom, yielding 0.50 gram of dark green oil. GCMS analysis showed 86.5% w/w urushiol. Further purification was achieved by column chromatography (15 centimeter length by 4 centimeter diameter) using a dry packed thiazole silica gel medium, and fractions were eluted with chloroform under laboratory vacuum. The purity was 91.5%. Concentrated extract was resuspended in ethanol and stored in a refrigerator.
- Silica (25 grams) was suspended in 200 milliliters of dry toluene before adding 10 milliliters of 3-aminopropyltriethoxysilane. The mixture was stirred and refluxed for 24 hours under a nitrogen atmosphere. The resulting product was filtered and washed twice with 50 milliliters of toluene, twice with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane. The product was dried for 6 hours at room temperature under laboratory vacuum, and then immersed in 200 milliliters of toluene prior to adding 6.25 milliliters of ethyl-2-bromopropionate. The mixture was again stirred and refluxed for 24 hours under a nitrogen atmosphere. The resulting product was filtered and washed twice with 50 milliliters of toluene, four times with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane. The resulting product was dried for 6 hours at room temperature under laboratory vacuum, dispersed in 200 milliliters of dry acetonitrile, and then 8.3 grams of 2-(thiazol-4-yl)ethanamine was added. The mixture was stirred and refluxed for 24 hours under a nitrogen atmosphere. The product was filtered and washed twice with 50 milliliters of acetonitrile, six times with 50 milliliters of ethanol, and four times with 50 milliliters of dichloromethane. This final product was dried at room temperature under vacuum to yield a thiazole silica gel.
- Urushiol congeners were separated as follows. An absorbance spectrum was obtained using purified extract showing maximum absorbance at 276 nanometers. High pressure liquid chromatography analysis was run on a C18 reverse phase column, and individual urushiol congener peaks were assessed by mass spectrometry (MS). Dried poison ivy urushiol was dissolved in ethanol and eluted with a 60 to 100% methanol gradient. Samples were collected and analyzed by MS. Preparative separation of urushiol components of the purified poison ivy extract was performed by reverse phase preparatory FPLC.
- Solvent Removal
- Urushiol extract prepared using methylene chloride as the primary solvent was transferred into a round bottom flask and stripped of solvent using a rotary evaporator to near dryness. A sample taken therefrom for GCMS analysis, which indicated the presence of hexane and methylene chloride in the sample. The extract was thrice resuspended in approximately 150 milliliters of diethyl ether and stripped of solvent. Following resuspension in ethanol, the product contained no detectable amount of hexane or methylene chloride.
- A total of six samples (0.5 milliliter each) of urushiol preparations made as described herein using methylene chloride as the primary solvent. Sample concentrations were 50 milligrams per milliliter, 5 milligrams per milliliter, and 0.5 milligram per milliliter, and these samples were prepared in duplicate. One duplicate of each of the three samples was stored at 23 degrees Celsius and the other was stored at 3 degrees Celsius. Gas chromatography profiles were obtained periodically over the course of 249 days to monitor urushiol levels in the samples.
- Gas Chromatography-Mass Spectrometric Analysis of Urushiol
- Purified urushiol reconstituted into ethanol was subjected to gas chromatography followed by the determination of mass charge ratio on a Agilent Model 5973N GC-MS System with column C8 reverse column.
- Liquid Chromatographic Analysis of Urushiol
- High Pressure Liquid Chromatography (HPLC) analysis was run on C18 reversed phase column, to determine individual urushiol congener peaks by mass spectrometry on a Agilent Model 1100 LC-MS System. Dried poison ivy urushiol was dissolved in ethanol and eluted with a 60 to 100% methanol gradient. Samples were collected and analyzed by ion-trap mass spectrometry.
- The disclosure of every patent, patent application, and publication cited herein is hereby incorporated herein by reference in its entirety.
- While this subject matter has been disclosed with reference to specific embodiments, it is apparent that other embodiments and variations can be devised by others skilled in the art without departing from the true spirit and scope of the subject matter described herein. The appended claims include all such embodiments and equivalent variations.
Claims (19)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/646,198 US9580373B2 (en) | 2012-11-21 | 2013-11-21 | Extraction and purification of urushiol from botanical sources |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261729081P | 2012-11-21 | 2012-11-21 | |
| PCT/US2013/071355 WO2014081988A1 (en) | 2012-11-21 | 2013-11-21 | Extraction and purification of urushiol from botanical sources |
| US14/646,198 US9580373B2 (en) | 2012-11-21 | 2013-11-21 | Extraction and purification of urushiol from botanical sources |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20150284308A1 true US20150284308A1 (en) | 2015-10-08 |
| US9580373B2 US9580373B2 (en) | 2017-02-28 |
Family
ID=50776573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/646,198 Active US9580373B2 (en) | 2012-11-21 | 2013-11-21 | Extraction and purification of urushiol from botanical sources |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US9580373B2 (en) |
| WO (1) | WO2014081988A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110672750A (en) * | 2019-10-25 | 2020-01-10 | 皖西学院 | Method for determining urushiol in rhus chinensis fruit oil by using UPLC-MS (ultra performance liquid chromatography-mass spectrometry) |
| CN111517923A (en) * | 2020-04-30 | 2020-08-11 | 中国林业科学研究院林产化学工业研究所 | A method for complex separation of three unsaturated urushiol monomers by Ag+ coordination resin |
| CN116143741A (en) * | 2023-03-07 | 2023-05-23 | 中国林业科学研究院林产化学工业研究所 | A kind of preparation method of urushiol dimer with antibacterial activity |
| CN116271953A (en) * | 2023-03-07 | 2023-06-23 | 中国林业科学研究院林产化学工业研究所 | A kind of green micro-extraction method of urushiol compound in sumac |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7629006B2 (en) * | 2004-09-09 | 2009-12-08 | AZI Company, Ltd | Process for preparing extract from rhus verniciflua and pharmaceutical composition containing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3819726A (en) | 1972-07-24 | 1974-06-25 | Us Health Education & Welfare | Preparation of urushiol from poison ivy or poison oak |
| JP5793185B2 (en) * | 2010-05-24 | 2015-10-14 | スケルタル ダイナミクス エルエルシー | Device, instrument and method for treatment of multiaxial joints |
-
2013
- 2013-11-21 US US14/646,198 patent/US9580373B2/en active Active
- 2013-11-21 WO PCT/US2013/071355 patent/WO2014081988A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7629006B2 (en) * | 2004-09-09 | 2009-12-08 | AZI Company, Ltd | Process for preparing extract from rhus verniciflua and pharmaceutical composition containing the same |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110672750A (en) * | 2019-10-25 | 2020-01-10 | 皖西学院 | Method for determining urushiol in rhus chinensis fruit oil by using UPLC-MS (ultra performance liquid chromatography-mass spectrometry) |
| CN111517923A (en) * | 2020-04-30 | 2020-08-11 | 中国林业科学研究院林产化学工业研究所 | A method for complex separation of three unsaturated urushiol monomers by Ag+ coordination resin |
| CN116143741A (en) * | 2023-03-07 | 2023-05-23 | 中国林业科学研究院林产化学工业研究所 | A kind of preparation method of urushiol dimer with antibacterial activity |
| CN116271953A (en) * | 2023-03-07 | 2023-06-23 | 中国林业科学研究院林产化学工业研究所 | A kind of green micro-extraction method of urushiol compound in sumac |
Also Published As
| Publication number | Publication date |
|---|---|
| US9580373B2 (en) | 2017-02-28 |
| WO2014081988A1 (en) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kanani et al. | Chemotaxonomic significance of the essential oils of 18 Ferula species (Apiaceae) from Iran | |
| JP2005532398A (en) | Hydroxytyrosol-enriched composition from olive plant water and methods of use thereof | |
| Dasgupta | Abuse of magic mushroom, peyote cactus, LSD, khat, and volatiles | |
| US9580373B2 (en) | Extraction and purification of urushiol from botanical sources | |
| Ayari-Guentri et al. | Chemical composition and antioxidant activity of Hyoscyamus muticus L. subsp. falezlez (Coss.) Maire from Algeria | |
| KR100460133B1 (en) | Production Method of Catechin with High Antioxidative Activity from The Extracts of Rosa davurica Pall | |
| Shah et al. | Qualitative and quantitative estimation or chemical constituents from leaves and roots of Iraqi Agave Attenuata by GC-MS and RP-HPLC (Conference Paper) | |
| Nwidu et al. | Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models | |
| Eslami et al. | Antioxidant activity of polyphenol and flavonoid rich extracts from leaves of myrtle (Myrtus communis L.) | |
| Banpure12 et al. | Anti-alzhimer activity of Bay leaves in scopolamine-induced rat model | |
| Coelho et al. | Calcium oxalate crystals and methyl salicylate as toxic principles of the fresh leaves from Palicourea longiflora, an endemic species in the Amazonas state | |
| Anh et al. | Characterization of volatile components from ethyl acetate extract of Stixis suaveolens (Roxb.) by comprehensive two‐dimensional gas chromatography hyphenated with a time‐of‐flight mass spectrometer | |
| Alex et al. | Antioxidant activities and phytochemical screening of peanut (Arachis hypogea) leaves | |
| VESCAN et al. | Several lipophilic components of five elite genotypes of Romanian seabuckthorn (Hippophae rhamnoides subs. carpatica) | |
| Porwal et al. | Comparative invitro antioxidant activty of Pongamia pinnata Linn. leaves extracts and isolated compound | |
| US6444235B1 (en) | Canelo products and methods of making and using same | |
| EP3922633A1 (en) | Method for extracting pyrrolizidine alkaloids | |
| Dawidar et al. | Chemical composition and effect of photo-oxygenation on biological activities of Egyptian commercial anise and fennel essential oils | |
| Fejes et al. | Antioxidant activity of different compounds from Anthriscus cerefolium L.(Hoffm.) | |
| AU2014330796B2 (en) | Extracts and compositions of Helichrysum odoratissimum for preventing and treating skin cancers | |
| AHMAD et al. | In Vitro ANTITRYPANOSOMAL ACTIVITY OF CAMPESTEROL AND ETHYL OLEATE FROM THE METHANOL EXTRACT OF Abrusprecatorius Linn | |
| US6428826B1 (en) | Chilco product and method of making and using same | |
| EP3120832B1 (en) | Use of leontopodic acid as a marker of an immortelle root extract | |
| Phungula | Studies towards the development of African phytomedicines from Combretum apiculatum and Galenia africana | |
| Ibrahim et al. | Successive solvent extraction and free radical scavenging activity of Azadirachta indica A. juss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: ROWAN UNIVERSITY, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YANG, CATHERINE F.;LI, WEIXING;ELLIOT, RYAN;AND OTHERS;SIGNING DATES FROM 20150609 TO 20150702;REEL/FRAME:037185/0346 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |